{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:45:50Z","timestamp":1793285150817,"version":"4.5.0"},"reference-count":256,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2024YFC2311503"],"award-info":[{"award-number":["2024YFC2311503"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322042"],"award-info":[{"award-number":["82322042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272248"],"award-info":[{"award-number":["82272248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102360"],"award-info":[{"award-number":["82102360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Ningxia \u2013 Outstanding Youth Program","award":["2024AAC05061"],"award-info":[{"award-number":["2024AAC05061"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Military Medical Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s40779-025-00660-w","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:06:28Z","timestamp":1761131188000},"page":"69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments"],"prefix":"10.1016","volume":"12","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia\u2011Xiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u2011Qi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi\u2011Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi\u2011Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2011Hang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju\u2011Dun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2011Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(23)00055-5","article-title":"New nomenclature for mpox (monkeypox) and monkeypox virus clades","volume":"23","author":"Ulaeto","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/s40779-025-00660-w_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2022.10.002","article-title":"The evolving epidemiology of monkeypox virus","volume":"68","author":"Li","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jiph.2022.10.002","article-title":"Monkeypox virus: future role in human population","volume":"15","author":"Farasani","year":"2022","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41591-024-03370-3","article-title":"Global genomic surveillance of monkeypox virus","volume":"31","author":"Otieno","year":"2025","journal-title":"Nat Med"},{"issue":"6619","key":"10.1186\/s40779-025-00660-w_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.add4153","article-title":"Multiple lineages of monkeypox virus detected in the United States, 2021\u20132022","volume":"378","author":"Gigante","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib6","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/s41591-023-02456-8","article-title":"Distinct monkeypox virus lineages co-circulating in humans before 2022","volume":"29","author":"Ndodo","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"10.1186\/s40779-025-00660-w_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multicountry outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"issue":"21","key":"10.1186\/s40779-025-00660-w_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216388","article-title":"Genetic variability of the monkeypox virus clade IIb B.1","volume":"11","author":"Scarpa","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2022.12513","article-title":"The WHO declaration of monkeypox as a global public health emergency","volume":"328","author":"Nuzzo","year":"2022","journal-title":"JAMA"},{"issue":"19","key":"10.1186\/s40779-025-00660-w_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N Engl J Med"},{"issue":"38","key":"10.1186\/s40779-025-00660-w_bib11","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.38.2400592","article-title":"Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, democratic republic of the Congo, July to August 2024","volume":"29","author":"Wawina-Bokalanga","year":"2024","journal-title":"Euro Surveill"},{"issue":"33","key":"10.1186\/s40779-025-00660-w_bib12","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.33.240815v","article-title":"Note from the editors: WHO declares mpox outbreak a public health emergency of international concern","volume":"29","author":"Eurosurveillance Editorial Team","year":"2024","journal-title":"Euro Surveill"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.15537\/1658-3175.8449","article-title":"WHO director-general declares mpox outbreak a public health emergency of international concern","volume":"45","year":"2024","journal-title":"Saudi Med J"},{"issue":"29","key":"10.1186\/s40779-025-00660-w_bib14","doi-asserted-by":"crossref","first-page":"34419","DOI":"10.1021\/acsami.3c04285","article-title":"Rapid detection of the monkeypox virus genome and antigen proteins based on surface-enhanced Raman spectroscopy","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bsheal.2022.10.005","article-title":"Development of 2 multiplex real-time PCR assays for simultaneous detection and differentiation of monkeypox virus IIa, IIb, and I clades and the B.1 lineage","volume":"4","author":"Huo","year":"2022","journal-title":"Biosaf Health"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bsheal.2022.09.004","article-title":"The current emergence of monkeypox: The recurrence of another smallpox?","volume":"4","author":"Lu","year":"2022","journal-title":"Biosaf Health"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28429","article-title":"Monkeypox diagnostics: review of current and emerging technologies","volume":"95","author":"Lim","year":"2023","journal-title":"J Med Virol"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41541-022-00527-4","article-title":"Current status of monkeypox vaccines","volume":"7","author":"Gruber","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1186\/s40779-025-00660-w_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110206","article-title":"Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention","volume":"119","author":"Kandeel","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"20","key":"10.1186\/s40779-025-00660-w_bib22","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human monkeypox virus infection in the immediate period after receiving modified vaccinia ankara vaccine","volume":"328","author":"Hazra","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat Med"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/10600280231151751","article-title":"Brincidofovir: a novel agent for the treatment of smallpox","volume":"57","author":"Huston","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"13","key":"10.1186\/s40779-025-00660-w_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-018-0967-6","article-title":"Tecovirimat: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1186\/s40779-025-00660-w_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1360586","article-title":"A comprehensive review of monkeypox virus and monkeypox characteristics","volume":"14","author":"Alakunle","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bmb\/ldad002","article-title":"Monkeypox: a review of the 2022 outbreak","volume":"145","author":"Lim","year":"2023","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28036","article-title":"Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022","volume":"95","author":"Wang","year":"2023","journal-title":"J Med Virol"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib31","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3201\/eid2912.231146","article-title":"Tecovirimat resistance in monkeypox patients, United States, 2022\u20132023","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"10380","key":"10.1186\/s40779-025-00660-w_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"monkeypox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tips.2023.08.003","article-title":"Differences in pathogenicity among the monkeypox virus clades: impact on drug discovery and vaccine development","volume":"44","author":"Andrei","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib34","first-page":"29","article-title":"Monkeypox outbreak: a novel threat after COVID-19?","volume":"9","author":"Zhang","year":"2022","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib35","first-page":"96","article-title":"Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial","volume":"4","author":"Denkinger","year":"2023","journal-title":"Nat Cancer"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158190","article-title":"Antibodies from convalescent plasma promote SARSCoV-2 clearance in individuals with and without endogenous antibody response","volume":"132","author":"Marconato","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1186\/s40779-025-00660-w_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57877","article-title":"Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization","volume":"9","author":"Klasse","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41591-019-0412-8","article-title":"Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic","volume":"25","author":"Caskey","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib39","first-page":"702","article-title":"Development of monoclonal antibody-based antigen detection assays for orthopoxvirus and monkeypox virus","volume":"85","author":"Li","year":"2022","journal-title":"J Infect"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib41","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001","volume":"206","author":"Lederman","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","article-title":"Monkeypox (formerly monkeypox): pathogenesis, prevention, and treatment","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"10.1186\/s40779-025-00660-w_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27185898","article-title":"Kinetic and structural aspects of glycosaminoglycan-monkeypox virus protein A29 interactions using surface plasmon resonance","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib44","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib45","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J Virol"},{"issue":"17","key":"10.1186\/s40779-025-00660-w_bib46","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1128\/JVI.00852-08","article-title":"Vaccinia virus l1 protein is required for cell entry and membrane fusion","volume":"82","author":"Bisht","year":"2008","journal-title":"J Virol"},{"issue":"16","key":"10.1186\/s40779-025-00660-w_bib47","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.78.16.8885-8901.2004","article-title":"Vaccinia virus morphogenesis: A13 phosphoprotein is required for assembly of mature virions","volume":"78","author":"Unger","year":"2004","journal-title":"J Virol"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib48","doi-asserted-by":"crossref","first-page":"e02155","DOI":"10.1128\/JVI.02155-19","article-title":"Vaccinia virus glycoproteins A33, A34, and B5 form a complex for efficient endoplasmic reticulum to trans-golgi network transport","volume":"94","author":"Monticelli","year":"2020","journal-title":"J Virol"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048706","article-title":"Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies","volume":"7","author":"Crickard","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47328-y","article-title":"Synergistic effect of 2 human-like monoclonal antibodies confers protection against orthopoxvirus infection","volume":"15","author":"Tamir","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11071179","article-title":"A monoclonal antibody produced in glycoengineered plants potently neutralizes monkeypox virus","volume":"11","author":"Esqueda","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204151","article-title":"Monkeypox multiantigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.06.029","article-title":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","volume":"418","author":"Xu","year":"2011","journal-title":"Virology"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2223669","article-title":"Three neutralizing mabs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus","volume":"12","author":"Li","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1186\/s40779-025-00660-w_bib55","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.2147\/IJN.S431619","article-title":"Screening, expression and identification of nanobody against monkeypox virus A35R","volume":"18","author":"Meng","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib56","article-title":"Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1186\/s40779-025-00660-w_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13568-023-01507-0","article-title":"Monkeypox epidemic at the door: should we remain idly by or prepare strongly?","volume":"13","author":"Al-Kuraishy","year":"2023","journal-title":"AMB Express"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.virol.2008.12.019","article-title":"Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans","volume":"385","author":"Foo","year":"2009","journal-title":"Virology"},{"issue":"Pt 5","key":"10.1186\/s40779-025-00660-w_bib60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1099\/vir.0.80831-0","article-title":"Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans","volume":"86","author":"Carter","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1186\/s40779-025-00660-w_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125515","article-title":"Immunogenic proteins and potential delivery platforms for monkeypox virus vaccine development: a rapid review","volume":"245","author":"Wang","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"17","key":"10.1186\/s40779-025-00660-w_bib62","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/emboj.2011.245","article-title":"Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture","volume":"30","author":"Schmidt","year":"2011","journal-title":"Embo J"},{"issue":"Pt 7","key":"10.1186\/s40779-025-00660-w_bib63","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1099\/vir.0.009092-0","article-title":"Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane","volume":"90","author":"Roberts","year":"2009","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1186\/s40779-025-00660-w_bib64","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1073\/pnas.0601025103","article-title":"Ligand-induced and nonfusogenic dissolution of a viral membrane","volume":"103","author":"Law","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1186\/s40779-025-00660-w_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10081034","article-title":"Poxvirus interactions with the host ubiquitin system","volume":"10","author":"Lant","year":"2021","journal-title":"Pathogens"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib66","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.celrep.2012.09.003","article-title":"RNAi screening reveals proteasome- and cullin3-dependent stages in vaccinia virus infection","volume":"2","author":"Mercer","year":"2012","journal-title":"Cell Rep"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib67","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3390\/v6103787","article-title":"From crescent to mature virion: vaccinia virus assembly and maturation","volume":"6","author":"Liu","year":"2014","journal-title":"Viruses"},{"issue":"22","key":"10.1186\/s40779-025-00660-w_bib68","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1128\/JVI.02137-13","article-title":"Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5","volume":"87","author":"Maruri-Avidal","year":"2013","journal-title":"J Virol"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib69","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1091\/mbc.12.7.2031","article-title":"Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei","volume":"12","author":"Tolonen","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"Pt 4","key":"10.1186\/s40779-025-00660-w_bib70","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1099\/vir.0.049486-0","article-title":"Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein","volume":"94","author":"Breiman","year":"2013","journal-title":"J Gen Virol"},{"issue":"17","key":"10.1186\/s40779-025-00660-w_bib71","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1128\/JVI.00598-06","article-title":"Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins","volume":"80","author":"Perdiguero","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib72","first-page":"151","article-title":"Antigen recognition and immune response to monkeypox virus infection: implications for monkeypox vaccine design\u2014a narrative review","volume":"33","author":"Abebaw","year":"2025","journal-title":"Infez Med"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003129","article-title":"Kinetics of antigen expression and epitope presentation during virus infection","volume":"9","author":"Croft","year":"2013","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib74","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.4049\/jimmunol.171.11.5668","article-title":"Cutting edge: Efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells","volume":"171","author":"Serna","year":"2003","journal-title":"J Immunol"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib75","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/JVI.03244-14","article-title":"Modified vaccinia virus ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways","volume":"89","author":"Thiele","year":"2015","journal-title":"J Virol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077804","article-title":"Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions","volume":"8","author":"Song","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","article-title":"CD4 memory T cells: What are they and what can they do?","volume":"21","author":"MacLeod","year":"2009","journal-title":"Semin Immunol"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib79","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2013.01.004","article-title":"Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin","volume":"13","author":"Hickman","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2009.04.004","article-title":"The immunology of smallpox vaccines","volume":"21","author":"Kennedy","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib82","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.chom.2022.11.003","article-title":"Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans","volume":"30","author":"Grifoni","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004123","article-title":"T cell inactivation by poxviral B22 family proteins increases viral virulence","volume":"10","author":"Alzhanova","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1186\/s40779-025-00660-w_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104424","article-title":"The landscape of immune response to monkeypox virus","volume":"87","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"Pt A","key":"10.1186\/s40779-025-00660-w_bib85","article-title":"Poxviruses and the immune system: implications for monkeypox virus","volume":"113","author":"Saghazadeh","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib86","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/CVI.00148-07","article-title":"Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection","volume":"14","author":"Karem","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib87","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib88","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1074\/mcp.M110.001875","article-title":"Characterization of macaque pulmonary fluid proteome during monkeypox infection: dynamics of host response","volume":"9","author":"Brown","year":"2010","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib89","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","article-title":"Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation","volume":"176","author":"Liszewski","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib90","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11262-023-01975-3","article-title":"Molecular detection of monkeypox and related viruses: challenges and opportunities","volume":"59","author":"Ghate","year":"2023","journal-title":"Virus Genes"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib91","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/acsnano.9b04224","article-title":"Present and future of surface-enhanced raman scattering","volume":"14","author":"Langer","year":"2020","journal-title":"ACS Nano"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib92","first-page":"326","article-title":"Advances in nano silver-based biomaterials and their biomedical applications","volume":"5","author":"Babu","year":"2024","journal-title":"Eng Regen"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220072","article-title":"Recent advances of Au@Ag core-shell SERS-based biosensors","volume":"3","author":"Awiaz","year":"2023","journal-title":"Exploration"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib94","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2332665","article-title":"Rapid identification of A29l antibodies based on mrna immunization and high-throughput single B cell sequencing to detect monkeypox virus","volume":"13","author":"Sun","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jviromet.2012.08.023","article-title":"Evaluation of the tetracore orthopox biothreat\u00ae antigen detection assay using laboratory-grown orthopoxviruses and rash illness clinical specimens","volume":"187","author":"Townsend","year":"2013","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib96","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1039\/D2AN02043B","article-title":"Gold-based paper for antigen detection of monkeypox virus","volume":"148","author":"Ye","year":"2023","journal-title":"Analyst"},{"key":"10.1186\/s40779-025-00660-w_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.132136","article-title":"Molybdenum disulfideloaded multilayer aunps with colorimetric-sers dual-signal enhancement activities for flexible immunochromatographic diagnosis of monkeypox virus","volume":"459","author":"Yu","year":"2023","journal-title":"J Hazard Mater"},{"key":"10.1186\/s40779-025-00660-w_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342514","article-title":"A rapid and sensitive fluorescent chromatography with cloud system for mpxv point-of-care diagnosis","volume":"1302","author":"Yan","year":"2024","journal-title":"Anal Chim Acta"},{"key":"10.1186\/s40779-025-00660-w_bib99","doi-asserted-by":"crossref","unstructured":"Wang W, Wang J, Hu Z, Yan X, Gao Q, Li X, et al. Advancing aggregation\u2010induced emission\u2010derived biomaterials in viral, tuberculosis, and fungal infectious diseases. Aggregate. 2024.","DOI":"10.1002\/agt2.715"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib100","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1002\/agt2.559","article-title":"Aggregationbased analytical chemistry in point-of-care nanosensors","volume":"5","author":"Li","year":"2024","journal-title":"Aggregate"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib101","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1002\/agt2.551","article-title":"Ultrabright nir aiegen nanoparticles-enhanced lateral flow immunoassay platform for accurate diagnostics of complex samples","volume":"5","author":"Shu","year":"2024","journal-title":"Aggregate"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib102","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12951-023-02215-4","article-title":"Fluorescence-enhanced dual signal lateral flow immunoassay for flexible and ultrasensitive detection of monkeypox virus","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1186\/s40779-025-00660-w_bib103","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcis.2023.12.188","article-title":"Fabrication of label-free immunoprobe for monkeypox A29 detection using one-step electrodeposited molybdenum oxide-graphene quantum rods","volume":"660","author":"Chandran","year":"2024","journal-title":"J Colloid Interface Sci"},{"issue":"50","key":"10.1186\/s40779-025-00660-w_bib104","doi-asserted-by":"crossref","first-page":"58079","DOI":"10.1021\/acsami.3c10730","article-title":"Electrochemical paper-based nanobiosensor for rapid and sensitive detection of monkeypox virus","volume":"15","author":"de Lima","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib105","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1002\/agt2.620","article-title":"Functional probes for the diagnosis and treatment of infectious diseases","volume":"5","author":"Fan","year":"2024","journal-title":"Aggregate"},{"key":"10.1186\/s40779-025-00660-w_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116313","article-title":"Development of a CRISPR\/Cas12a-mediated aptasensor for mpox virus antigen detection","volume":"257","author":"Han","year":"2024","journal-title":"Biosens Bioelectron"},{"issue":"24","key":"10.1186\/s40779-025-00660-w_bib107","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1021\/acs.nanolett.3c02709","article-title":"Selective singlemolecule nanopore detection of monkeypox A29 protein directly in biofluids","volume":"23","author":"Cai","year":"2023","journal-title":"Nano Lett"},{"key":"10.1186\/s40779-025-00660-w_bib108","series-title":"Target product profiles for tests used for monkeypox (monkeypox) diagnosis","author":"Organization WH","year":"2023"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15212\/bioi-2024-0002","article-title":"Aptamer-based theranostics in oncology: design strategies and limitations","volume":"5","author":"Trivedi","year":"2024","journal-title":"BIO Integr"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11427-022-2230-4","article-title":"Current progress in the development of prophylactic and therapeutic vaccines","volume":"66","author":"Li","year":"2023","journal-title":"Sci China Life Sci"},{"key":"10.1186\/s40779-025-00660-w_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122331","article-title":"Vaccine development: current trends and technologies","volume":"336","author":"Poria","year":"2024","journal-title":"Life Sci"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib112","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1529-8019.2009.01223.x","article-title":"Vaccine immunology","volume":"22","author":"Bartlett","year":"2009","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib113","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib114","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","article-title":"Prevention of monkeypox with vaccines: a rapid review","volume":"22","author":"Poland","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tips.2022.10.005","article-title":"Monkeypox: potential vaccine development strategies","volume":"44","author":"Lozano","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1186\/s40779-025-00660-w_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1456060","article-title":"Advancements in monkeypox vaccines development: a critical review of emerging technologies","volume":"15","author":"Garcia-Atutxa","year":"2024","journal-title":"Front Immunol"},{"issue":"18","key":"10.1186\/s40779-025-00660-w_bib117","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.cell.2022.08.002","article-title":"Monkeypox emergency: urgent questions and perspectives","volume":"185","author":"Rothenburg","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coviro.2011.11.007","article-title":"Poxvirus host cell entry","volume":"2","author":"Schmidt","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib119","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/MMBR.00026-09","article-title":"Poxvirus proteomics and virus-host protein interactions","volume":"73","author":"Van Vliet","year":"2009","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1186\/s40779-025-00660-w_bib120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","article-title":"Monkeypox virus and insights into its immunomodulatory proteins","volume":"225","author":"Weaver","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1186\/s40779-025-00660-w_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050309","article-title":"Strategy of developing nucleic acid-based universal monkeypox vaccine candidates","volume":"13","author":"Papukashvili","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015547","article-title":"Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination","volume":"5","author":"Keasey","year":"2010","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib123","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/v4050688","article-title":"Poxvirus cell entry: How many proteins does it take?","volume":"4","author":"Moss","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib125","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/jvi.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of vaccinia virus produced in escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J Virol"},{"issue":"21","key":"10.1186\/s40779-025-00660-w_bib126","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jobb.2022.12.004","article-title":"Potential threat of human pathogenic orthopoxviruses to public health and control strategies","volume":"5","author":"Zhang","year":"2023","journal-title":"J Biosaf Biosecur"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"19","key":"10.1186\/s40779-025-00660-w_bib130","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib131","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib132","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib133","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1186\/s40779-025-00660-w_bib134","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1128\/JVI.01149-06","article-title":"Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein","volume":"80","author":"Brown","year":"2006","journal-title":"J Virol"},{"issue":"18","key":"10.1186\/s40779-025-00660-w_bib135","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus h3l envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J Virol"},{"issue":"716","key":"10.1186\/s40779-025-00660-w_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci Transl Med"},{"issue":"20","key":"10.1186\/s40779-025-00660-w_bib137","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against monkeypox following mRNA or modified vaccinia ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib138","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against monkeypox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib139","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11427-023-2378-x","article-title":"Multivalent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity","volume":"66","author":"Zhang","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib141","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","article-title":"Polyvalent mrna vaccination elicited potent immune response to monkeypox virus surface antigens","volume":"33","author":"Fang","year":"2023","journal-title":"Cell Res"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114269","article-title":"Polyvalent monkeypox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29140","article-title":"Evaluation and comparison of immune responses induced by 2 monkeypox mRNA vaccine candidates in mice","volume":"95","author":"Yang","year":"2023","journal-title":"J Med Virol"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib144","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/vaccines12040385","article-title":"A quadrivalent mRNA immunization elicits potent immune responses against multiple orthopoxviral antigens and neutralization of monkeypox virus in rodent models","volume":"12","author":"Su","year":"2024","journal-title":"Vaccines"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib145","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3390\/v2091933","article-title":"Orthopoxvirus genome evolution: the role of gene loss","volume":"2","author":"Hendrickson","year":"2010","journal-title":"Viruses"},{"key":"10.1186\/s40779-025-00660-w_bib146","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-253045-6.50007-9","article-title":"The pathogenesis, pathology, and immunology of orthopoxvirus infections","author":"Fenner","year":"1989","journal-title":"The Orthopoxviruses"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib147","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/v15030668","article-title":"Research advances on the stability of mRNA vaccines","volume":"15","author":"Cheng","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib148","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ccell.2024.05.005","article-title":"RNA vaccines for cancer: principles to practice","volume":"42","author":"Guasp","year":"2024","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib149","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jis753","article-title":"Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia ankara as a smallpox vaccine in HIV-infected subjects","volume":"207","author":"Greenberg","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.46234\/ccdcw2024.025","article-title":"The current state and progress of monkeypox vaccine research","volume":"6","author":"Wang","year":"2024","journal-title":"China CDC Wkly"},{"issue":"15","key":"10.1186\/s40779-025-00660-w_bib151","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant-enhanced antibody responses to recombinant proteins correlate with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"issue":"40","key":"10.1186\/s40779-025-00660-w_bib152","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects nonhuman primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib153","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"23","key":"10.1186\/s40779-025-00660-w_bib154","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"key":"10.1186\/s40779-025-00660-w_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203410","article-title":"Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from monkeypox virus challenge","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11091420","article-title":"A subunit vaccine candidate composed of monkeypox virus A29L, M1R, A35R, and B6R elicits robust immune response in mice","volume":"11","author":"Yang","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202408608","article-title":"Programmable macrophage vesicle based bionic self-adjuvanting vaccine for immunization against monkeypox virus","volume":"12","author":"Lin","year":"2025","journal-title":"Adv Sci"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib158","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","article-title":"Rational design of a \u2018two-in-one\u2019 immunogen dam drives potent immune response against monkeypox virus","volume":"25","author":"Wang","year":"2024","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib159","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","article-title":"Multi-epitope vaccines: a promising strategy against tumors and viral infections","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13577-025-01255-2","article-title":"Multi-epitope vaccines: charting a new frontier in monkeypox prevention and control","volume":"38","author":"Tiwary","year":"2025","journal-title":"Hum Cell"},{"key":"10.1186\/s40779-025-00660-w_bib161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/ITT.S241064","article-title":"Immunoinformatics and vaccine development: an overview","volume":"9","author":"Oli","year":"2020","journal-title":"Immunotargets Ther"},{"key":"10.1186\/s40779-025-00660-w_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02315","article-title":"Bacterial vaccine antigen discovery in the reverse vaccinology 2.0 era: progress and challenges","volume":"9","author":"Bidmos","year":"2018","journal-title":"Front Immunol"},{"key":"10.1186\/s40779-025-00660-w_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112816","article-title":"Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches","volume":"14","author":"Tan","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib164","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tim.2008.07.009","article-title":"Vaccinia virus morphogenesis and dissemination","volume":"16","author":"Roberts","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1186\/s40779-025-00660-w_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1042997","article-title":"Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation","volume":"13","author":"Suleman","year":"2022","journal-title":"Front Immunol"},{"key":"10.1186\/s40779-025-00660-w_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035924","article-title":"Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a nextgeneration multi-valent peptide-based vaccine","volume":"13","author":"Yousaf","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20397-z","article-title":"Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach","volume":"12","author":"Shantier","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286224","article-title":"In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus","volume":"18","author":"Sanami","year":"2023","journal-title":"PLoS ONE"},{"issue":"Supplement_2","key":"10.1186\/s40779-025-00660-w_bib169","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1093\/infdis\/jiad443","article-title":"Immunoinformatic approach for rational identification of immunogenic peptides against host entry and\/or exit monkeypox proteins and potential multiepitope vaccine construction","volume":"229","author":"de Ara\u00fajo","year":"2024","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1186\/s40779-025-00660-w_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106893","article-title":"Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for monkeypox virus (mpxv) against the recent outbreak","volume":"159","author":"Jin","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1186\/s40779-025-00660-w_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106497","article-title":"Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus","volume":"153","author":"Singh","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1186\/s40779-025-00660-w_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1091941","article-title":"Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets","volume":"14","author":"Waqas","year":"2023","journal-title":"Front Immunol"},{"key":"10.1186\/s40779-025-00660-w_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.985450","article-title":"Multiepitope chimeric vaccine design against emerging monkeypox virus via reverse vaccinology techniques-a bioinformatics and immunoinformatics approach","volume":"13","author":"Aiman","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/v14112374","article-title":"Immunoinformatics-aided design of a peptide based multiepitope vaccine targeting glycoproteins and membrane proteins against monkeypox virus","volume":"14","author":"Akhtar","year":"2022","journal-title":"Viruses"},{"issue":"38","key":"10.1186\/s40779-025-00660-w_bib176","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1073\/pnas.0800589105","article-title":"Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation","volume":"105","author":"Hammarlund","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1186\/s40779-025-00660-w_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126498","article-title":"Exploring the whole proteome of monkeypox virus to design B-cell epitope-based oral vaccines using immunoinformatics approaches","volume":"252","author":"Pritam","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/v14112504","article-title":"Multi-epitope vaccine for monkeypox using pan-genome and reverse vaccinology approaches","volume":"14","author":"Swetha","year":"2022","journal-title":"Viruses"},{"issue":"16","key":"10.1186\/s40779-025-00660-w_bib179","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1080\/07391102.2023.2248301","article-title":"Delineating multi-epitope vaccine designing from membrane protein CL5 against all monkeypox strains: a pangenome reverse vaccinology approach","volume":"42","author":"Alsaiari","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib180","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02862-22","article-title":"The potential role of passive antibody-based therapies as treatments for monkeypox","volume":"13","author":"Bloch","year":"2022","journal-title":"MBio"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib181","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/cid\/ciac971","article-title":"The use of vaccinia immune globulin in the treatment of severe monkeypox. Virus infection in human immunodeficiency virus\/aids","volume":"76","author":"Thet","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1186\/s40779-025-00660-w_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10071084","article-title":"Protective human antipoxvirus monoclonal antibodies are generated from rare memory B cells isolated by multicolor antigen tetramers","volume":"10","author":"Gu","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib183","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib184","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/v2102381","article-title":"Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections","volume":"2","author":"Xiao","year":"2010","journal-title":"Viruses"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib186","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","article-title":"Human monkeypox and smallpox viruses: genomic comparison","volume":"509","author":"Shchelkunov","year":"2001","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib187","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jama.2022.10802","article-title":"Monkeypox in 2022-what clinicians need to know","volume":"328","author":"Guarner","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib188","article-title":"Monkeypox: from emerging trends to therapeutic concerns","volume":"16","author":"Piparva","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib189","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1473-3099(23)00054-3","article-title":"Treatment and prevention of monkeypox in pregnant people and young children","volume":"23","author":"Khalil","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib190","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S1473-3099(22)00612-0","article-title":"Monkeypox in pregnancy: update on current outbreak","volume":"22","author":"Khalil","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/s40779-025-00660-w_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105179","article-title":"A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge","volume":"195","author":"Parker","year":"2021","journal-title":"Antivir Res"},{"issue":"7\u20138","key":"10.1186\/s40779-025-00660-w_bib192","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/protein\/gzy017","article-title":"Analysis of nanobody paratopes reveals greater diversity than classical antibodies","volume":"31","author":"Mitchell","year":"2018","journal-title":"Protein Eng Des Sel"},{"key":"10.1186\/s40779-025-00660-w_bib193","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2018.02.012","article-title":"Recent advances in the selection and identification of antigen-specific nanobodies","volume":"96","author":"Liu","year":"2018","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib194","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/07357907.2018.1458858","article-title":"Nanobodies and cancer: current status and new perspectives","volume":"36","author":"Allegra","year":"2018","journal-title":"Cancer Invest"},{"issue":"19","key":"10.1186\/s40779-025-00660-w_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28196838","article-title":"In vitro affinity maturation of nanobodies against monkeypox virus A29 protein based on computer-aided design","volume":"28","author":"Yu","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib196","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus l1r open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"10.1186\/s40779-025-00660-w_bib197","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-0716-2241-4_11","article-title":"Technoeconomic modeling and simulation for plant-based manufacturing of recombinant proteins","volume":"2480","author":"McNulty","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"8","key":"10.1186\/s40779-025-00660-w_bib198","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","article-title":"Technoeconomic analysis of a transient plant-based platform for monoclonal antibody production","volume":"8","author":"Nandi","year":"2016","journal-title":"MAbs"},{"issue":"34","key":"10.1186\/s40779-025-00660-w_bib199","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1073\/pnas.1610803113","article-title":"Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms","volume":"113","author":"Chen","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2018.1466767","article-title":"The, \u201cless-is-more\u201d in therapeutic antibodies: afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity","volume":"10","author":"Pereira","year":"2018","journal-title":"MAbs"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib201","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/bit.26503","article-title":"N-glycan engineering of a plant-produced anti-CD20-HIL-2 immunocytokine significantly enhances its effector functions","volume":"115","author":"Marusic","year":"2018","journal-title":"Biotechnol Bioeng"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005148","article-title":"Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer","volume":"11","author":"Matho","year":"2015","journal-title":"PLoS Pathog"},{"issue":"17","key":"10.1186\/s40779-025-00660-w_bib203","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib204","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s40779-025-00660-w_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106156","article-title":"Progress and prospects on vaccine development against monkeypox infection","volume":"180","author":"Saadh","year":"2023","journal-title":"Microb Pathog"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006581","article-title":"Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease","volume":"12","author":"Mucker","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1186\/s40779-025-00660-w_bib207","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.omtn.2022.05.025","article-title":"Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits","volume":"28","author":"Mucker","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-024-01766-8","article-title":"Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses","volume":"9","author":"Chi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib209","article-title":"Antibiotic-loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria","volume":"19","author":"Wang","year":"2024","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib210","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1002\/agt2.434","article-title":"A pH-responsive nanoparticle delivery system containing dihydralazine and doxorubicin-based prodrug for enhancing antitumor efficacy","volume":"5","author":"Zhang","year":"2023","journal-title":"Aggregate"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib211","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bsheal.2022.03.013","article-title":"Biosafety materials for tuberculosis treatment","volume":"4","author":"Wang","year":"2022","journal-title":"Biosaf Health"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib212","doi-asserted-by":"crossref","first-page":"344","DOI":"10.20517\/evcna.2024.19","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design","volume":"5","author":"Hagedorn","year":"2024","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib213","first-page":"199","article-title":"Microalgae-based drug delivery system for tumor microenvironment photo-modulating and synergistic chemo-photodynamic therapy of osteosarcoma","volume":"5","author":"Liang","year":"2024","journal-title":"Eng Regen"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib214","first-page":"361","article-title":"Microalgae-based drug delivery systems in biomedical applications","volume":"5","author":"Huang","year":"2024","journal-title":"Eng Regen"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib215","first-page":"131","article-title":"Living cell for drug delivery","volume":"3","author":"Wu","year":"2022","journal-title":"Eng Regen"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib216","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12951-024-02786-w","article-title":"Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy","volume":"22","author":"Ijaz","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib217","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15212\/bioi-2022-0015","article-title":"Optimization of ultra-small nanoparticles for enhanced drug delivery","volume":"4","author":"He","year":"2023","journal-title":"BIO Integration"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib218","doi-asserted-by":"crossref","first-page":"618","DOI":"10.20517\/evcna.2024.61","article-title":"Engineered extracellular vesicles as \u201csupply vehicles\u201d to alleviate type 1 diabetes","volume":"5","author":"Wang","year":"2024","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12429","article-title":"Synthetic biologybased bacterial extracellular vesicles displaying BMP-2 and CXCR-4 to ameliorate osteoporosis","volume":"13","author":"Liu","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1186\/s40779-025-00660-w_bib220","first-page":"169","article-title":"Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives","volume":"14","author":"Liu","year":"2022","journal-title":"Bioact Mater"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib221","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to combat viral infections: development strategies and progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib222","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"11","author":"Garegnani","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib223","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305378","article-title":"Aggregation-induced emission-based macrophage-like nanoparticles for targeted photothermal therapy and virus transmission blockage in monkeypox","volume":"36","author":"Li","year":"2024","journal-title":"Adv Mater"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib224","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1002\/agt2.587","article-title":"A self-regulated phototheranostic nanosystem with single wavelength-triggered energy switching and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections","volume":"5","author":"Wang","year":"2024","journal-title":"Aggregate"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib225","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230113","article-title":"Intelligent bacteria-targeting ZIF-8 composite for fluorescence imaging-guided photodynamic therapy of drug-resistant superbug infections and burn wound healing","volume":"4","author":"Li","year":"2024","journal-title":"Exploration"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib226","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","article-title":"Photothermal therapy of tuberculosis using targeting pre-activated macrophage membranecoated nanoparticles","volume":"19","author":"Li","year":"2024","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib227","first-page":"59","article-title":"Photosensitizers with aggregation-induced emission and their biomedical applications","volume":"3","author":"Chen","year":"2022","journal-title":"Eng Regen"},{"issue":"13","key":"10.1186\/s40779-025-00660-w_bib228","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003556","article-title":"Antiviral and antiinflammatory treatment with multifunctional alveolar macrophagelike nanoparticles in a surrogate mouse model of COVID-19","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci"},{"issue":"29","key":"10.1186\/s40779-025-00660-w_bib229","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402103","article-title":"Extracellular vesicleinspired therapeutic strategies for the COVID-19","volume":"13","author":"Hu","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib230","first-page":"427","article-title":"Biomimetic extracellular vesicles for the tumor targeted treatment","volume":"4","author":"Shi","year":"2023","journal-title":"Eng Regen"},{"issue":"2","key":"10.1186\/s40779-025-00660-w_bib231","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230112","article-title":"A review of monkeypox: biological characteristics, epidemiology, clinical features, diagnosis, treatment, and prevention strategies","volume":"5","author":"Jiang","year":"2024","journal-title":"Exploration"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib232","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bsheal.2023.10.002","article-title":"Establishment and application of national reference panels for SARS-CoV-2 antigen detection kit","volume":"5","author":"Ma","year":"2023","journal-title":"Biosaf Health"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib233","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bsheal.2021.09.001","article-title":"The impact of sample processing on the rapid antigen detection test for SARS-CoV-2: virus inactivation, VTM selection, and sample preservation","volume":"3","author":"Zhou","year":"2021","journal-title":"Biosaf Health"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib234","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220012","article-title":"Keeping up with the COVID\u2019s\u2014Could siRNA-based antivirals be a part of the answer?","volume":"2","author":"Forgham","year":"2022","journal-title":"Exploration"},{"issue":"6","key":"10.1186\/s40779-025-00660-w_bib235","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210217","article-title":"mRNA nanomedicine: design and recent applications","volume":"2","author":"Kubiatowicz","year":"2022","journal-title":"Exploration"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210082","article-title":"Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemic","volume":"2","author":"Wang","year":"2022","journal-title":"Exploration"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib237","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","article-title":"Monkeypox: epidemiology, pathogenesis, treatment and prevention","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1186\/s40779-025-00660-w_bib238","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"issue":"4","key":"10.1186\/s40779-025-00660-w_bib239","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1186\/s40779-025-00660-w_bib240","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9272","article-title":"A gametheoretic model of monkeypox to assess vaccination strategies","volume":"8","author":"Bankuru","year":"2020","journal-title":"PeerJ"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111882","article-title":"In vivo electroporation of plasmid DNA: a promising strategy for rapid, inexpensive, and flexible delivery of antiviral monoclonal antibodies","volume":"13","author":"Pagant","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1186\/s40779-025-00660-w_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115099","article-title":"Exploring the future of SARS-CoV-2 treatment after the first 2 years of the pandemic: a comparative study of alternative therapeutics","volume":"165","author":"Babalola","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib243","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ijms19010054","article-title":"Development of antibody therapeutics against flaviviruses","volume":"19","author":"Sun","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1186\/s40779-025-00660-w_bib244","first-page":"1","article-title":"The landscape of neutralizing monoclonal antibodies (nAbs) for treatment and prevention of COVID-19","author":"de Almeida Oliveira","year":"2023","journal-title":"J Pharm Innov"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib245","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41409-023-02072-7","article-title":"Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T cell) therapya guidance by the GOCART Coalition pharmacist working group","volume":"58","author":"Nezvalova-Henriksen","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1186\/s40779-025-00660-w_bib246","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41409-020-0983-5","article-title":"Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT","volume":"56","author":"Faulkner","year":"2021","journal-title":"PDWP Bone Marrow Transplant"},{"issue":"11","key":"10.1186\/s40779-025-00660-w_bib247","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac551","article-title":"Beyond sex: human monkeypox virus is an emerging threat to marginalized populations","volume":"9","author":"Barocas","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1186\/s40779-025-00660-w_bib248","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3201\/eid2809.221051","article-title":"Epidemiologic features and control measures during monkeypox outbreak, Spain, June 2022","volume":"28","author":"Su\u00e1rez Rodr\u00edguez","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1186\/s40779-025-00660-w_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2021.100086","article-title":"Access to antivenoms in the developing world: a multidisciplinary analysis","volume":"12","author":"Potet","year":"2021","journal-title":"Toxicon X"},{"key":"10.1186\/s40779-025-00660-w_bib250","article-title":"Clinical manifestations of human monkeypox infection and implications for outbreak strategy","volume":"5","author":"Johri","year":"2022","journal-title":"Health Sci Rev"},{"issue":"5","key":"10.1186\/s40779-025-00660-w_bib251","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s10461-024-04271-9","article-title":"Perception and awareness about monkeypox and vaccination acceptance in an at-risk population in Brescia, Italy: an investigative survey","volume":"28","author":"Crosato","year":"2024","journal-title":"AIDS Behav"},{"issue":"10","key":"10.1186\/s40779-025-00660-w_bib252","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/tropicalmed7100276","article-title":"Prevention, risk exposure, and knowledge of monkeypox in occupational settings: a scoping review","volume":"7","author":"Lulli","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"24","key":"10.1186\/s40779-025-00660-w_bib253","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192416781","article-title":"Human monkeypox global public health emergency","volume":"19","author":"Zardi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib254","first-page":"55","article-title":"Monkeypox outbreak in the age of COVID-19: a new global health emergency","volume":"9","author":"Hirani","year":"2022","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib255","first-page":"31","article-title":"An unfolding monkeypox outbreak in Europe and beyond","volume":"9","author":"Wallau","year":"2022","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1186\/s40779-025-00660-w_bib256","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12929-021-00728-4","article-title":"Applications of brain organoids in neurodevelopment and neurological diseases","volume":"28","author":"Sun","year":"2021","journal-title":"J Biomed Sci"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00660-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-025-00660-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00660-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:42:22Z","timestamp":1787139742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2054936926000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":256,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2054936926000762"],"URL":"https:\/\/doi.org\/10.1186\/s40779-025-00660-w","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments","name":"articletitle","label":"Article Title"},{"value":"Military Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s40779-025-00660-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, http:\/\/creativecommons.org\/licenses\/by\/4.0\/, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"69"}}